Bladder cancer

被引：16
作者：
不详
机构：
[1] Department of Molecular Medicine, Aarhus University Hospital, Aarhus
[2] Department of Clinical Medicine, Aarhus University, Aarhus
[3] Division of Pathology and Laboratory Medicine, University of Texas MD Anderson Cancer Center, Houston, TX
[4] Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA
[5] Division of Molecular Medicine, Leeds Institute of Medical Research at St James’s, St James’s University Hospital, Leeds
[6] Division of Hematology and Medical Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY
[7] S.H. Ho Urology Centre, Department of Surgery, The Chinese University of Hong Kong
[8] Department of Urology, Cedars-Sinai Medical Center, Los Angeles, CA
[9] Department of Pathology and Laboratory Medicine, Cedars-Sinai Medical Center, Los Angeles, CA
[10] Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA
来源：
NATURE REVIEWS DISEASE PRIMERS | 2023年 / 9卷 / 01期
关键词：
D O I：
10.1038/s41572-023-00475-w
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
This PrimeView highlights the epidemiology of bladder cancer and accompanies the Primer article on this topic by Dyrskjot et al.
引用
收藏
页数：1
相关论文
共 331 条
  • [21] Validating a Local Failure Risk Stratification for Use in Prospective Studies of Adjuvant Radiation Therapy for Bladder Cancer
    Baumann, Brian C.
    He, Jiwei
    Hwang, Wei-Ting
    Tucker, Kai N.
    Bekelman, Justin E.
    Herr, Harry W.
    Lerner, Seth P.
    Guzzo, Thomas J.
    Malkowicz, S. Bruce
    Christodouleas, John P.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 95 (02): : 703 - 706
  • [22] Beer N., 1910, JAMA, VLIV, P1768, DOI [10.1001/jama.1910.92550480001001c, DOI 10.1001/JAMA.1910.92550480001001C]
  • [23] DNA Damage and Oxidative Stress of Tobacco Smoke Condensate in Human Bladder Epithelial Cells
    Bellamri, Medjda
    Walmsley, Scott J.
    Brown, Christina
    Brandt, Kyle
    Konorev, Dmitri
    Day, Abderrahman
    Wu, Chia-Fang
    Wu, Ming Tsang
    Turesky, Robert J.
    [J]. CHEMICAL RESEARCH IN TOXICOLOGY, 2022, 35 (10) : 1863 - 1880
  • [24] Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma
    Bellmunt, J.
    de Wit, R.
    Vaughn, D. J.
    Fradet, Y.
    Lee, J. -L.
    Fong, L.
    Vogelzang, N. J.
    Climent, M. A.
    Petrylak, D. P.
    Choueiri, T. K.
    Necchi, A.
    Gerritsen, W.
    Gurney, H.
    Quinn, D. I.
    Culine, S.
    Sternberg, C. N.
    Mai, Y.
    Poehlein, C. H.
    Perini, R. F.
    Bajorin, D. F.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2017, 376 (11) : 1015 - 1026
  • [25] Adjuvant atezolizumab versus observation in muscle-invasive urothelial carcinoma (IMvigor010): a multicentre, open-label, randomised, phase 3 trial
    Bellmunt, Joaquim
    Hussain, Maha
    Gschwend, Jurgen E.
    Albers, Peter
    Oudard, Stephane
    Castellano, Daniel
    Daneshmand, Siamak
    Nishiyama, Hiroyuki
    Majchrowicz, Martin
    Degaonkar, Viraj
    Shi, Yi
    Mariathasan, Sanjeev
    Grivas, Petros
    Drakaki, Alexandra
    O'Donnell, Peter H.
    Rosenberg, Jonathan E.
    Geynisman, Daniel M.
    Petrylak, Daniel P.
    Hoffman-Censits, Jean
    Bedke, Jens
    Kalebasty, Arash Rezazadeh
    Zakharia, Yousef
    van der Heijden, Michiel S.
    Sternberg, Cora N.
    Davarpanah, Nicole N.
    Powles, Thomas
    [J]. LANCET ONCOLOGY, 2021, 22 (04) : 525 - 537
  • [26] Genomic Predictors of Good Outcome, Recurrence, or Progression in High-Grade T1 Non-Muscle-Invasive Bladder Cancer
    Bellmunt, Joaquim
    Kim, Jaegil
    Reardon, Brendan
    Perera-Bel, Julia
    Orsola, Anna
    Rodriguez-Vida, Alejo
    Wankowicz, Stephanie A.
    Bowden, Michaela
    Barletta, Justine A.
    Morote, Juan
    de Torres, Ines
    Juanpere, Nuria
    Lloreta-Trull, Josep
    Hernandez, Silvia
    Mouw, Kent W.
    Taplin, Mary-Ellen
    Cejas, Paloma
    Long, Henry W.
    Van Allen, Eliezer M.
    Getz, Gad
    Kwiatkowski, David J.
    [J]. CANCER RESEARCH, 2020, 80 (20) : 4476 - 4486
  • [27] Stem-Like Signature Predicting Disease Progression in Early Stage Bladder Cancer. The Role of E2F3 and SOX4
    Bellmunt, Joaquim
    [J]. BIOMEDICINES, 2018, 6 (03)
  • [28] Phase III Trial of Vinflunine Plus Best Supportive Care Compared With Best Supportive Care Alone After a Platinum-Containing Regimen in Patients With Advanced Transitional Cell Carcinoma of the Urothelial Tract
    Bellmunt, Joaquim
    Theodore, Christine
    Demkov, Tomasz
    Komyakov, Boris
    Sengelov, Lisa
    Daugaard, Gedske
    Caty, Armelle
    Carles, Joan
    Jagiello-Gruszfeld, Agnieszka
    Karyakin, Oleg
    Delgado, Francois-Michel
    Hurteloup, Patrick
    Morsli, Nassim
    Salhi, Yacine
    Culine, Stephane
    von der Maase, Hans
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (27) : 4454 - 4461
  • [29] Berglund R. K., 2011, Campbell-Walsh Urology, V10th
  • [30] Bondaruk J, 2022, ISCIENCE, V25, DOI 10.1016/j.isci.2022.104551
12345678910